HB Wealth Management LLC Sells 1,783 Shares of The Clorox Company $CLX

HB Wealth Management LLC trimmed its stake in shares of The Clorox Company (NYSE:CLX) by 36.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,168 shares of the company’s stock after selling 1,783 shares during the quarter. HB Wealth Management LLC’s holdings in Clorox were worth $380,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also made changes to their positions in the company. American National Bank & Trust increased its stake in shares of Clorox by 69.5% in the second quarter. American National Bank & Trust now owns 217 shares of the company’s stock valued at $26,000 after buying an additional 89 shares in the last quarter. Ransom Advisory Ltd bought a new stake in shares of Clorox during the first quarter worth approximately $35,000. GW&K Investment Management LLC lifted its holdings in Clorox by 239.1% in the first quarter. GW&K Investment Management LLC now owns 295 shares of the company’s stock valued at $43,000 after buying an additional 208 shares during the period. Roble Belko & Company Inc boosted its stake in Clorox by 140.7% in the first quarter. Roble Belko & Company Inc now owns 361 shares of the company’s stock valued at $53,000 after acquiring an additional 211 shares during the last quarter. Finally, IMA Advisory Services Inc. acquired a new stake in Clorox during the 1st quarter worth $58,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Insider Buying and Selling

In other news, COO Eric H. Reynolds sold 15,041 shares of the stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the transaction, the chief operating officer directly owned 54,221 shares in the company, valued at $6,711,475.38. This represents a 21.72% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 0.57% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several research analysts have recently issued reports on the company. Jefferies Financial Group reduced their price target on Clorox from $167.00 to $145.00 and set a “buy” rating on the stock in a research report on Thursday, June 26th. Morgan Stanley reduced their target price on Clorox from $150.00 to $137.00 and set an “equal weight” rating on the stock in a report on Friday, August 1st. UBS Group cut their price target on shares of Clorox from $150.00 to $134.00 and set a “neutral” rating on the stock in a research report on Thursday, July 17th. Barclays lowered their target price on shares of Clorox from $118.00 to $112.00 and set an “underweight” rating for the company in a research note on Tuesday, September 30th. Finally, The Goldman Sachs Group reduced their price target on shares of Clorox from $115.00 to $110.00 and set a “sell” rating on the stock in a research report on Wednesday, October 1st. One equities research analyst has rated the stock with a Buy rating, ten have given a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Reduce” and a consensus target price of $134.08.

Clorox Stock Up 0.9%

NYSE:CLX opened at $123.30 on Monday. The stock has a 50-day simple moving average of $122.81 and a 200 day simple moving average of $129.41. The Clorox Company has a 52-week low of $116.53 and a 52-week high of $171.37. The company has a market cap of $15.08 billion, a PE ratio of 18.91, a PEG ratio of 1.00 and a beta of 0.52. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84.

Clorox (NYSE:CLX) last released its quarterly earnings results on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, topping analysts’ consensus estimates of $2.24 by $0.63. The firm had revenue of $1.99 billion during the quarter, compared to the consensus estimate of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.During the same quarter in the prior year, the firm posted $1.82 EPS. The business’s revenue was up 4.5% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, sell-side analysts expect that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd will be paid a $1.24 dividend. This represents a $4.96 annualized dividend and a yield of 4.0%. The ex-dividend date is Wednesday, October 22nd. Clorox’s payout ratio is presently 76.07%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.